Double-blind, placebo-controlled, 1:1 randomized Phase III clinical trial of Immunoxel honey lozenges as an adjunct immunotherapy in 269 patients with pulmonary tuberculosis.

Autor: Batbold, Uyanga, Butov, Dmytro O, Kutsyna, Galyna A, Damdinpurev, Narantsetseg, Grinishina, Elena A, Mijiddorj, Otgonbayar, Kovolev, Mikola E, Baasanjav, Khaliunaa, Butova, Tatyana S, Sandagdorj, Munkhburam, Batbold, Ochirbat, Tseveendorj, Ariungerel, Chunt, Erkhemtsetseg, Zaitzeva, Svetlana I, Stepanenko, Hanna L, Makeeva, Natalia I, Mospan, Igor V, Pylypchuk, Volodymyr S, Rowe, John L, Nyasulu, Peter
Zdroj: Immunotherapy (1750743X); Jan2017, Vol. 9 Issue 1, p13-24, 12p
Databáze: Complementary Index